The malaria diagnostics market is poised to reach about USD 180 million by 2022. It was valued around USD 144.6 million in 2015. The key market drivers include demand for these devices across malaria-affected nations, need for cost-efficient diagnostic methods, and health awareness.
Malaria is a life-threatening disease, with 214 million cases detected in 2015, as per the World Health Organization (WHO). About 3.2 billion citizens were at a risk of getting this disease the same year. But technological advances in diagnostic kits helped prevent this pandemic.
Full research report on malaria diagnostics market analysis:
http://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market
Countries like Oman, Georgia, the UAE (United Arab Emirates), Argentina, Armenia, and Iraq have reported zero indigenous cases of malaria. This coupled with demand for cost-efficient diagnostic devices is expected to restrict the malaria diagnostics market.
The market is split by technologies into Rapid Diagnostic Tests (RDTs), microscopy, and others. RDTs occupied 63% shares in 2015 and will experience high growth in the forecast period (2015 to 2022). They should enjoy 4.1% CAGR in the coming seven years. Rapid results and high sensitivity drive this technology.
Microscopy would grow at around 3.7% CAGR, in terms of volumes, from 2015 to 2022. In 2013, over 190 million patients adopted this method. Out of this, 120 slide examinations were conducted in India that year. Regions under the malaria diagnostics market include America, Europe, East Mediterranean, Africa, West Pacific, and Southeast Asia.
Request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market/request
Africa enjoyed nearly 58.2% shares as of 2015. It is projected to account for the biggest shares (60%) by 2022. This can be attributed to regional demand for RDTs & other malaria diagnostic products. Factors favoring Africa are also its underdeveloped healthcare, poverty, local weather, and socio-economic instability.
Southeast Asia occupied second position in the market. India was among the leading users. India is poised to expand at around 3.8% CAGR in the next seven years. But declining malaria cases in this nation can negatively affect its market. Bhutan, Sri Lanka, and Korea are in the pre-elimination zero malaria phase.
Prominent players of the worldwide malaria diagnostics market are Premier Medical Corporation, Alere Inc., Access Bio Inc., Sysmex Partec GmbH, and Siemens Healthcare. In 2015, Alere joined hands with Standard Diagnostics to create RDTs for sleeping sickness and malaria.
View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Web: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: sales@grandviewresearch.com
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market